GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pou1f1 | mm39_v1_chr16_+_65317389_65317434 | -0.15 | 3.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_87074380 Show fit | 72.86 |
ENSMUST00000031183.3
|
UDP glucuronosyltransferase 2 family, polypeptide B1 |
|
chr5_-_87485023 Show fit | 52.30 |
ENSMUST00000031195.3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
|
chr4_-_60457902 Show fit | 52.16 |
ENSMUST00000084548.11
ENSMUST00000103012.10 ENSMUST00000107499.4 |
major urinary protein 1 |
|
chr4_-_60777462 Show fit | 51.95 |
ENSMUST00000211875.2
|
major urinary protein 22 |
|
chr4_-_60697274 Show fit | 48.09 |
ENSMUST00000117932.2
|
major urinary protein 12 |
|
chr4_-_61259997 Show fit | 47.31 |
ENSMUST00000071005.9
ENSMUST00000075206.12 |
major urinary protein 14 |
|
chr4_-_60222580 Show fit | 46.32 |
ENSMUST00000095058.5
ENSMUST00000163931.8 |
major urinary protein 8 |
|
chr8_-_94006345 Show fit | 36.95 |
ENSMUST00000034178.9
|
carboxylesterase 1F |
|
chr4_-_61437704 Show fit | 36.61 |
ENSMUST00000095051.6
ENSMUST00000107483.8 |
major urinary protein 16 |
|
chr4_-_60538151 Show fit | 35.29 |
ENSMUST00000098047.3
|
major urinary protein 10 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 187.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
5.9 | 82.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
6.9 | 75.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
24.3 | 72.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.5 | 39.6 | GO:0007566 | embryo implantation(GO:0007566) |
12.3 | 37.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
11.6 | 34.8 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.0 | 34.5 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
8.6 | 34.3 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.4 | 31.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 333.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
5.8 | 52.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 32.5 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 32.2 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 31.8 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 21.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 16.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 15.8 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 13.9 | GO:0032420 | stereocilium(GO:0032420) |
0.5 | 13.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 254.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
3.9 | 115.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.4 | 62.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
9.3 | 55.5 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
17.4 | 52.2 | GO:0005009 | insulin-activated receptor activity(GO:0005009) |
1.0 | 50.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
11.2 | 44.8 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 43.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
11.6 | 34.8 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
10.6 | 31.7 | GO:0005186 | pheromone activity(GO:0005186) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 13.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 11.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 10.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 8.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 7.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 5.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 5.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 4.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 4.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 3.6 | PID ENDOTHELIN PATHWAY | Endothelins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 64.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 56.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.8 | 40.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
2.2 | 24.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 19.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
5.3 | 15.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 13.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.6 | 13.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.1 | 12.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 9.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |